These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3113730)

  • 1. Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma.
    Creagan ET; Ahmann DL; Long HJ; Frytak S; Sherwin SA; Chang MN
    Cancer Treat Rep; 1987 Sep; 71(9):843-4. PubMed ID: 3113730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recombinant leukocyte A interferon in metastasized malignant melanoma].
    Elsässer-Beile U; Schöpf E; Neumann HA; Drews H; Hundhammer K; Balda BR
    Dtsch Med Wochenschr; 1987 Mar; 112(10):373-7. PubMed ID: 3816582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanoma.
    Dorval T; Palangie T; Jouve M; Garcia-Giralt E; Israel L; Falcoff E; Schwab D; Pouillart P
    Cancer; 1986 Jul; 58(2):215-8. PubMed ID: 3719515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I study of i.v. administered recombinant gamma interferon in cancer patients.
    Kurzrock R; Quesada JR; Rosenblum MG; Sherwin SA; Gutterman JU
    Cancer Treat Rep; 1986 Dec; 70(12):1357-64. PubMed ID: 3098417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eastern cooperative group trial of interferon gamma in metastatic melanoma: an innovative study design.
    Schiller JH; Pugh M; Kirkwood JM; Karp D; Larson M; Borden E
    Clin Cancer Res; 1996 Jan; 2(1):29-36. PubMed ID: 9816086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High-dose Roncoleukin in patients with disseminated cutaneous melanoma: a phase 1 study].
    Moiseenko VM; Novik AV; Orlova RV; Protsenko SA; Mikhaĭlichenko TD; Semenova AI; Tiukavina NV
    Vopr Onkol; 2005; 51(5):546-9. PubMed ID: 16756008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of recombinant human interferon-gamma in metastatic renal cell carcinoma.
    Bruntsch U; de Mulder PH; ten Bokkel Huinink WW; Clavel M; Drozd A; Kaye SB; Renard J; van Glabbeke M
    J Biol Response Mod; 1990 Jun; 9(3):335-8. PubMed ID: 2116500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
    Kuzmits R; Scheithauer W; Ludwig H; Flener R
    Acta Med Austriaca; 1985; 12(5):129-34. PubMed ID: 3938590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of recombinant interferon gamma by 1-hour i.v. infusion.
    Vadhan-Raj S; Nathan CF; Sherwin SA; Oettgen HF; Krown SE
    Cancer Treat Rep; 1986 May; 70(5):609-14. PubMed ID: 3085930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II studies of recombinant human interferon gamma in metastatic renal cell carcinoma.
    Quesada JR; Kurzrock R; Sherwin SA; Gutterman JU
    J Biol Response Mod; 1987 Feb; 6(1):20-7. PubMed ID: 3104544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of concurrent twice-weekly recombinant human interleukin-12 plus low-dose IL-2 in patients with melanoma or renal cell carcinoma.
    Gollob JA; Veenstra KG; Parker RA; Mier JW; McDermott DF; Clancy D; Tutin L; Koon H; Atkins MB
    J Clin Oncol; 2003 Jul; 21(13):2564-73. PubMed ID: 12829677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response.
    Gollob JA; Mier JW; Veenstra K; McDermott DF; Clancy D; Clancy M; Atkins MB
    Clin Cancer Res; 2000 May; 6(5):1678-92. PubMed ID: 10815886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Green SJ
    Cancer Treat Rep; 1982 Jun; 66(6):1425-6. PubMed ID: 7083244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.
    Weiner LM; Moldofsky PJ; Gatenby RA; O'Dwyer J; O'Brien J; Litwin S; Comis RL
    Cancer Res; 1988 May; 48(9):2568-73. PubMed ID: 3128400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant interferon-gamma (immuneron): results of a phase I trial in patients with cancer.
    van der Burg M; Edelstein M; Gerlis L; Liang CM; Hirschi M; Dawson A
    J Biol Response Mod; 1985 Jun; 4(3):264-72. PubMed ID: 3926954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of an aziridinylbenzoquinone (AZQ) in disseminated malignant melanoma.
    Creagan ET; Schutt AJ; Ahmann DL; Green SJ
    Cancer Treat Rep; 1982 Dec; 66(12):2089-90. PubMed ID: 7139650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic use of alpha interferon in metastasizing malignant melanoma, disseminated Kaposi sarcoma and severe Behçet disease].
    Stadler R; Bratzke B; Orfanos CE
    Hautarzt; 1987 Aug; 38(8):453-60. PubMed ID: 3654216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma treatment of metastasized malignant melanoma.
    Haase KD; Lange OF; Scheef W
    Anticancer Res; 1987; 7(3 Pt B):335-6. PubMed ID: 3115173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase I study of a recombinant gamma interferon (S-6810)].
    Ogawa M; Takaku F; Maekawa T; Ota K; Ichimaru M; Izuo M; Takakura K; Ikeda S; Koiso K; Machida T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):446-52. PubMed ID: 3101608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
    Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
    Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.